HPV does not select its host according to gender, and neither should protection. We must provide our sons with the same level of protection that we provide for our daughters.
Malaysia has made headway in its goal to eliminate cervical cancer by 2030, with cervical cancer incidence falling in the past decade based on a new cancer registry report, but advocates say challenges remain with HPV vaccination, screening, and treatment.
All Form 1 girls in 2022 and 2023 cohorts in Malaysia missed HPV vaccination due to vaccine shortages. Only 52% of 2021 cohort completed HPV vax. MOH says 50,000 HPV vaccine doses received in Jan 2024 will be prioritised for unvaccinated in 2021 cohort.
The Life Insurance Association of Malaysia donates RM3 million to the National Cancer Society Malaysia's multi-sectoral HPV vaccination drive that aims to roll out 300,000 doses for marginalised women and girls across all 222 parliamentary constituencies.
A multi-sectoral HPV vaccination drive, with 300,000 vaccine doses donated by MSD, aims to vaccinate girls across all 222 parliament constituencies. The programme, driven by NCSM, will work with MPs’ offices, district health offices and community leaders.
Dr Adeeba Kamarulzaman says eliminating cervical cancer requires partnerships and collective action. "Our vision for Malaysia is clear: a future where cervical cancer is a rare disease and where women have access to timely screenings & HPV vaccinations."
First dose HPV vaccination coverage in Malaysia dove during the Covid-19 pandemic among girls aged 15+ from 82% in 2020 to 14% in 2021, before climbing to 39% in 2022. Among girls before age 15, HPV vax coverage dropped to 82% in 2022 from 94% in 2019.
Malaysia's adaptable strategies highlight its unwavering dedication to reducing the burden of cervical cancer and other HPV-related cancers and diseases.
Prof Dr Adeeba Kamarulzaman says Malaysia only needs to invest RM1,200 per woman for HPV vaccination and testing to save lives from cervical cancer. ROSE Foundation founder Prof Dr Woo Yin Ling says the cervical cancer "end game" will protect future generations.
A total of 336,592 eligible girls from the 2020, 2021, and 2022 cohorts have not yet received their HPV vaccination despite the Ministry of Health’s ongoing catch-up efforts.